Disse bestemmelser træder i stedet for den administrerende direktørs afgørelse af 3. december 1997 om regler for aktindsigt i EMEA’ s dokumenter.
These will focus on providing better information on action taken by the Agency on medicines once they are already in use by patients and in animals.